易方达全球医药行业美元(008285)
动态评分： 4.05分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2024-12-31 | 09969 | 诺诚健华 | 2433.57 | 2.59% |
| 2024-12-31 | JANX | Janux Therapeutics Inc | 2342.95 | 2.5% |
| 2024-12-31 | 02186 | 绿叶制药 | 2287.32 | 2.44% |
| 2024-12-31 | 06618 | 京东健康 | 2050.51 | 2.19% |
| 2024-12-31 | PTGX | Protagonist Therapeutics Inc | 1923.8 | 2.05% |
| 2024-12-31 | 09688 | 再鼎医药 | 1910.65 | 2.04% |
| 2024-12-31 | 06127 | 昭衍新药 | 1885.38 | 2.01% |
| 2024-12-31 | RVMD | Revolution Medicines Inc | 1855.3 | 1.98% |
| 2024-12-31 | KYMR | Kymera Therapeutics Inc | 1823.17 | 1.94% |
| 2024-12-31 | LEGN | Legend Biotech Corp ADR | 1643.03 | 1.75% |
| 2024-12-31 | 02373 | 美丽田园医疗健康 | 1617.86 | 1.72% |
| 2024-12-31 | 09996 | 沛嘉医疗-B | 1507.43 | 1.61% |
| 2024-12-31 | ALNY | Alnylam Pharmaceuticals Inc | 1444.71 | 1.54% |
| 2024-12-31 | 02256 | 和誉-B | 1372.93 | 1.46% |
| 2024-12-31 | 02096 | 先声药业 | 1220.96 | 1.3% |
| 2024-12-31 | 02190 | 归创通桥-B | 1215.78 | 1.3% |
| 2024-12-31 | STAA | STAAR Surgical Co | 1212.31 | 1.29% |
| 2024-12-31 | 02500 | 启明医疗-B | 687.23 | 0.73% |
| 2024-12-31 | 02552 | 华领医药-B | 607.15 | 0.65% |
| 2024-12-31 | CGEM | Cullinan Therapeutics Inc | 599.5 | 0.64% |
公告&资料
